Intellectual Property India Publishes Patent Application for Crystalline Forms Of 3-(1-(( 1 R,4r,5s)-2-Azabicyclo[2.1.1 ]hexan-5-Yl)-2-(( 1 R,3r,5r)-2-( Cyclopropanecarbonyl)-2-Azabicyclo[3.1.0]hexan-3-Yl)-7-(2,3-Dichlorophenyl)-6-Fluoro-4-Methyl-1 H-Pyrrolo[3,2- C]quinolin-8-Yl)propanenitrile

MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617058145 A) filed by Incyte Corporation on May 07, 2026, for Crystalline Forms Of 3-(1-(( 1 R,4r,5s)-2-Azabicyclo[2.1.1 ]hexan-5-Yl)-2-(( 1 R,3r,5r)-2-( Cyclopropanecarbonyl)-2-Azabicyclo[3.1.0]hexan-3-Yl)-7-(2,3-Dichlorophenyl)-6-Fluoro-4-Methyl-1 H-Pyrrolo[3,2- C]quinolin-8-Yl)propanenitrile.

Inventors include Hu, Jiemin; Jia, Zhongjiang; Sheth, Trupti Number; Su, Naijing; and Zhang, Huaping.

The application for the patent was published on June 05, 2026, under issue no. 23/2026.

Abstract: This disclosure provides salts, crystalline forms, and formulations of a KRAS inhibitor, and methods of making and using thereof.

Disclaimer: Curated by HT Syndication.